DD123343A5 - - Google Patents
Info
- Publication number
- DD123343A5 DD123343A5 DD189666A DD18966675A DD123343A5 DD 123343 A5 DD123343 A5 DD 123343A5 DD 189666 A DD189666 A DD 189666A DD 18966675 A DD18966675 A DD 18966675A DD 123343 A5 DD123343 A5 DD 123343A5
- Authority
- DD
- German Democratic Republic
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB51240/74A GB1533235A (en) | 1974-11-26 | 1974-11-26 | Benzodiazepine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DD123343A5 true DD123343A5 (en) | 1976-12-12 |
Family
ID=10459213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD189666A DD123343A5 (en) | 1974-11-26 | 1975-11-25 |
Country Status (30)
Country | Link |
---|---|
JP (1) | JPS6044314B2 (en) |
AR (1) | AR221203A1 (en) |
AT (1) | AT351547B (en) |
AU (1) | AU506340B2 (en) |
BE (1) | BE835932A (en) |
BG (1) | BG29573A3 (en) |
CA (1) | CA1075687A (en) |
CH (2) | CH613455A5 (en) |
CS (1) | CS236753B2 (en) |
DD (1) | DD123343A5 (en) |
DE (1) | DE2552403C2 (en) |
DK (1) | DK146887C (en) |
ES (1) | ES443011A1 (en) |
FR (1) | FR2292479A1 (en) |
GB (1) | GB1533235A (en) |
HK (1) | HK58681A (en) |
HU (1) | HU172493B (en) |
IE (1) | IE42564B1 (en) |
IL (1) | IL48502A (en) |
KE (1) | KE3163A (en) |
MY (1) | MY8200149A (en) |
NL (1) | NL186088C (en) |
NZ (1) | NZ179335A (en) |
PH (2) | PH11669A (en) |
PL (1) | PL100135B1 (en) |
RO (1) | RO69912A (en) |
SE (2) | SE421209B (en) |
SU (2) | SU629879A3 (en) |
YU (1) | YU298375A (en) |
ZA (1) | ZA757344B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL62792A (en) * | 1980-05-07 | 1985-02-28 | Byk Gulden Lomberg Chem Fab | Acylated dihydrothienodiazepinone compounds,process for their preparation,and medicaments containing them |
GB8819059D0 (en) * | 1988-08-11 | 1988-09-14 | Lilly Industries Ltd | Benzodiazepine compounds & their use as pharmaceuticals |
GB9009229D0 (en) * | 1990-04-25 | 1990-06-20 | Lilly Industries Ltd | Pharmaceutical compounds |
TW268005B (en) * | 1992-05-29 | 1996-01-11 | Lilly Industries Ltd | |
WO1997016430A1 (en) * | 1995-11-01 | 1997-05-09 | Merck & Co., Inc. | Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
US6043358A (en) | 1995-11-01 | 2000-03-28 | Merck & Co., Inc. | Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
WO1999011647A1 (en) | 1997-09-02 | 1999-03-11 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused thiophene compounds and medicinal use thereof |
PL199016B1 (en) * | 2002-06-20 | 2008-08-29 | Adamed Sp Z Oo | Method of manufacture of alanzapine, new derivative of n-demethyl olanzapine and method of manufacture of new derivative of n-demethyl olanzapine |
SI21270A (en) | 2002-07-15 | 2004-02-29 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Crystal forms of olanzapine and procedures for their preparation |
DE10301923B3 (en) * | 2003-01-17 | 2004-09-16 | Krka Tovarna Zdravil, D.D. | Process and intermediates for the production of olanzapine |
EP1720885A1 (en) * | 2004-01-27 | 2006-11-15 | Synthon B.V. | A process for making olanzapine in a polymorph form i |
AR048272A1 (en) | 2004-03-18 | 2006-04-12 | Lek Pharmaceuticals | SYNTHESIS OF 2 METHYL - 4- (4- METHYL -1- PIPERAZINIL) - 10 H- TIENO (2,3-B) (1,5) BENZODIAZEPIN AND ITS SALTS, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND ITS USE IN THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF MENTAL DISEASES. |
RU2485125C2 (en) * | 2004-06-30 | 2013-06-20 | Эсерсис, Инк. | SUBSTITUTED AZEPINE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING DISEASES, DISORDERS AND/OR PATHOLOGICAL CONDITIONS WHEREIN 5HT2c-RECEPTOR FUNCTION MODULATION IS DESIRABLE |
EP2292624A1 (en) | 2009-07-20 | 2011-03-09 | LEK Pharmaceuticals d.d. | Process for the purification of olanzapine |
-
1974
- 1974-11-25 SU SU742191705A patent/SU629879A3/en active
- 1974-11-26 GB GB51240/74A patent/GB1533235A/en not_active Expired
-
1975
- 1975-11-20 CA CA240,082A patent/CA1075687A/en not_active Expired
- 1975-11-20 DK DK524175A patent/DK146887C/en active
- 1975-11-20 IL IL48502A patent/IL48502A/en unknown
- 1975-11-21 PH PH17788A patent/PH11669A/en unknown
- 1975-11-21 AU AU86858/75A patent/AU506340B2/en not_active Expired
- 1975-11-22 DE DE2552403A patent/DE2552403C2/en not_active Expired
- 1975-11-24 NZ NZ179335A patent/NZ179335A/en unknown
- 1975-11-24 CH CH604478A patent/CH613455A5/en not_active IP Right Cessation
- 1975-11-24 CH CH1517275A patent/CH613454A5/en not_active IP Right Cessation
- 1975-11-24 ZA ZA757344A patent/ZA757344B/en unknown
- 1975-11-24 SE SE7513185A patent/SE421209B/en not_active IP Right Cessation
- 1975-11-25 DD DD189666A patent/DD123343A5/xx unknown
- 1975-11-25 JP JP50141080A patent/JPS6044314B2/en not_active Expired
- 1975-11-25 YU YU02983/75A patent/YU298375A/en unknown
- 1975-11-25 AR AR261340A patent/AR221203A1/en active
- 1975-11-25 RO RO7584018A patent/RO69912A/en unknown
- 1975-11-25 BE BE6045266A patent/BE835932A/en not_active IP Right Cessation
- 1975-11-25 FR FR7535900A patent/FR2292479A1/en active Granted
- 1975-11-25 IE IE2565/75A patent/IE42564B1/en unknown
- 1975-11-26 CS CS757991A patent/CS236753B2/en unknown
- 1975-11-26 PL PL1975184991A patent/PL100135B1/en unknown
- 1975-11-26 ES ES443011A patent/ES443011A1/en not_active Expired
- 1975-11-26 HU HU75LI00000284A patent/HU172493B/en unknown
- 1975-11-26 NL NLAANVRAGE7513833,A patent/NL186088C/en not_active IP Right Cessation
- 1975-11-26 AT AT898275A patent/AT351547B/en not_active IP Right Cessation
- 1975-11-26 BG BG7531601A patent/BG29573A3/en unknown
-
1976
- 1976-10-07 SU SU762406250A patent/SU626702A3/en active
-
1977
- 1977-02-22 PH PH19480A patent/PH24534A/en unknown
-
1978
- 1978-11-27 SE SE7812194A patent/SE429045B/en not_active IP Right Cessation
-
1981
- 1981-09-24 KE KE3163A patent/KE3163A/en unknown
- 1981-11-26 HK HK586/81A patent/HK58681A/en unknown
-
1982
- 1982-12-30 MY MY149/82A patent/MY8200149A/en unknown